IGF1R and neoplasm: In our study, anti-IGF-1R treatment in mice bearing orthotopic tumours of human cancer cells induced a period of stable disease followed by spontaneous metastasis and a reduced life span, which is debatably similar to the observations in clinical trials with figitumumab in combination with chemotherapy53.